Dana-Farber Cancer Institute Inc

EIN: 042263040 501(c)(3) Medical Research

BOSTON, MA

Total Revenue
$3,471,594,710
Total Expenses
$3,358,144,757
Total Assets
$5,348,876,627
Net Assets
$3,911,081,391
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1951
Legal Domicile
MA
Phone
6176323000
Tax Period
2023-10-01 to 2024-09-30

Dana-Farber Cancer Institute Inc, founded in 1951, is a large national nonprofit in the Medical Research sector that reported $3.5B in total revenue in fiscal year 2023. Expenses of $3.4B left a modest 3% surplus.

Mission

FOR THE FOLLOWING, BENEFITS REPORTED IN PART VII INCLUDES GROSS-UP PAYMENTS FOR AN EMPLOYEE RECOGNITION PROGRAM AWARD: 5 KEY EMPLOYEES 3 OFFICERS 1 HIGHEST-COMPENSATED EMPLOYEES

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $779,153,701
Program Service Revenue $2,611,491,064
Investment Income $5,694,108
Other Revenue $75,255,837
TOTAL REVENUE $3,471,594,710

Expense Breakdown

Grants Paid $7,580,997
Salaries & Benefits $1,082,475,984
Fundraising Expenses $50,705,899
Program Expenses $3,076,421,974
Other Expenses $2,262,455,426
TOTAL EXPENSES $3,358,144,757

Year-over-Year Comparison

2023 2022 Change
Revenue $3,471,594,710 $3,387,587,769 +0.0%
Expenses $3,358,144,757 $3,002,803,859 +0.1%
Net Income $113,449,953 $384,783,910 -0.7%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
65
Independent Members
64
Employees
9211
Volunteers
500

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
9
$5,733,922
Total Directors
71
$2,459,825
Key Employees
9
$6,045,550
Highest Compensated
5
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
JOHN J O'CONNOR Trustee & Treasurer (END 1/29/24) 2.0
Officer Director
$0 $0 $0
JOSHUA BEKENSTEIN Trustee & Chairman 2.0
Officer Director
$0 $0 $0
Laurie H Glimcher MD Trustee, President & CEO 44.0
Officer Director
$2,105,144 $354,681 $2,459,825
Lori Whelan Trustee, Treasurer (AS OF 1/29/24) 2.0
Officer Director
$0 $0 $0
Monica Chandra Trustee & Secretary 1.0
Officer Director
$0 $0 $0
Richard Lubin Trustee & Vice-Chairman 2.0
Officer Director
$0 $0 $0
Afsaneh Beschloss Trustee 1.0
Director
$0 $0 $0
Alison Jaffe Trustee 1.0
Director
$0 $0 $0
Amy Berylson Trustee 1.0
Director
$0 $0 $0
Amy Kyle ESQ Trustee 1.0
Director
$0 $0 $0
Andrew Janower Trustee 1.0
Director
$0 $0 $0
Andrew Kaplan Trustee 1.0
Director
$0 $0 $0
Beth Terrana Trustee 1.0
Director
$0 $0 $0
Betty Ann Blum Trustee 1.0
Director
$0 $0 $0
Bradley Lucas Trustee 1.0
Director
$0 $0 $0
Brian Knez Trustee 1.0
Director
$0 $0 $0
Christopher J Hadley Trustee 1.0
Director
$0 $0 $0
Demond Martin Trustee 1.0
Director
$0 $0 $0
Doug Grip Trustee 1.0
Director
$0 $0 $0
Elizabeth Clymer Trustee 1.0
Director
$0 $0 $0
Eric Miller Trustee 1.0
Director
$0 $0 $0
Eric Schlager Trustee (END 1/29/24) 1.0
Director
$0 $0 $0
Esta Stecher Trustee 1.0
Director
$0 $0 $0
Fatima Penrose Trustee 1.0
Director
$0 $0 $0
Frank Laukien Trustee 1.0
Director
$0 $0 $0
Frederica Williams Trustee 1.0
Director
$0 $0 $0
Gary Prado Trustee 1.0
Director
$0 $0 $0
Harvey Berger MD Trustee 1.0
Director
$0 $0 $0
Hise Gibson Trustee 1.0
Director
$0 $0 $0
James McCann Trustee 1.0
Director
$0 $0 $0
Jane Brock-Wilson Trustee 1.0
Director
$0 $0 $0
Jane Jamieson Trustee 1.0
Director
$0 $0 $0
Jennifer Perini Trustee 1.0
Director
$0 $0 $0
Jessica Knez Dulac Trustee 1.0
Director
$0 $0 $0
Jill Greenthal Trustee 1.0
Director
$0 $0 $0
Jodi Walker Trustee 1.0
Director
$0 $0 $0
Jose Aguerrevere Trustee 1.0
Director
$0 $0 $0
Karen Daley PHD MPH RN FANN Trustee 1.0
Director
$0 $0 $0
Karen Hale Trustee (END 4/5/24) 1.0
Director
$0 $0 $0
Karen Linde Packman Trustee 1.0
Director
$0 $0 $0
Kate Gulliver Trustee 1.0
Director
$0 $0 $0
Kevin DaSilva Trustee 1.0
Director
$0 $0 $0
Kimberly Sherman Stamler Trustee 1.0
Director
$0 $0 $0
Laura Sen Trustee 1.0
Director
$0 $0 $0
Levi Garraway Trustee 1.0
Director
$0 $0 $0
Lisa Ferraro Trustee 1.0
Director
$0 $0 $0
Louise Svanberg Trustee 1.0
Director
$0 $0 $0
Mary Ann Tocio Trustee (END 1/29/24) 1.0
Director
$0 $0 $0
Meg Reynolds Trustee 1.0
Director
$0 $0 $0
Michael Eisenson Trustee 1.0
Director
$0 $0 $0
Michael Trotsky Trustee 1.0
Director
$0 $0 $0
Moria Forbes Trustee 1.0
Director
$0 $0 $0
Nancy Gibson Trustee 1.0
Director
$0 $0 $0
Nancy Lotane Trustee 1.0
Director
$0 $0 $0
Paul Marcus Trustee 1.0
Director
$0 $0 $0
Peter Palandjian Trustee 1.0
Director
$0 $0 $0
Phillip Gross Trustee 1.0
Director
$0 $0 $0
Robert Reynolds Trustee 1.0
Director
$0 $0 $0
Robert Sachs Trustee (END 1/29/24) 1.0
Director
$0 $0 $0
Robert Stansky Trustee 1.0
Director
$0 $0 $0
Ronald Sullivan Trustee 1.0
Director
$0 $0 $0
Sandra Stratford MD Trustee 1.0
Director
$0 $0 $0
Stephen Fine Trustee (END 1/29/24) 1.0
Director
$0 $0 $0
Stephen Koster ESQ Trustee 1.0
Director
$0 $0 $0
Steven Koppel Trustee 1.0
Director
$0 $0 $0
Susan Alexander ESQ Trustee 1.0
Director
$0 $0 $0
Susan Poduska Trustee 1.0
Director
$0 $0 $0
Sushil Tuli Trustee 1.0
Director
$0 $0 $0
Theodore Pasquarello Trustee 1.0
Director
$0 $0 $0
Timothy Cohen Trustee 1.0
Director
$0 $0 $0
Tracey McCain ESQ Trustee 1.0
Director
$0 $0 $0
Jennifer Willcox ESQ Asst Secretary & General Counsel 50.0
Officer
$692,134 $83,219 $775,353
Michael L Reney CFO & Assistant Treasurer 46.0
Officer
$1,098,939 $50,077 $1,149,016
William Hahn MD PHD COO & EVP 49.0
Officer
$1,299,728 $50,000 $1,349,728
Barrett J Rollins MD PHD Sr. Advisor to President & CEO 50.0
Key Emp
$546,650 $57,960 $604,610
Benjamin Ebert MD PhD CHAIR OF MEDICAL ONCOLOGY 49.0
Key Emp
$209,100 $15,127 $224,227
Craig A Bunnell MD MPH MBA Chief Medical Officer 50.0
Key Emp
$963,956 $53,398 $1,017,354
Jeffrey Meyerhardt MD MPH Chief Clinical Research Officer 50.0
Key Emp
$720,117 $89,568 $809,685
Kevin Haigis PHD Chief Scientific Officer 50.0
Key Emp
$667,828 $50,797 $718,625
Maria Megdal SVP Chief Administrative Officer 50.0
Key Emp
$670,345 $68,528 $738,873
Melany Duval SVP & Chief Philanthropy Officer 50.0
Key Emp
$938,328 $68,330 $1,006,658
Sylvia A Bartel RPh MHP SR. VP of Pharmacy & CPO 50.0
Key Emp
$360,265 $86,038 $446,303
Wendy Gettleman VP of Facilities Management & Real Estate 50.0
Key Emp
$389,597 $89,618 $479,215
Bruce Johnson MD Sr. Advisor to President & CEO 49.0
Highest
$749,341 $73,538 $822,879
Elizabeth Liebow Former Key Employee 0.0
Highest
$1,205,871 $51,580 $1,257,451
Michael Constantine MD Milford Med Dir-Hematology/Oncology 50.0
Highest
$800,852 $89,666 $890,518
Robert Soiffer MD Chair Executive Committee for Clinical Programs 50.0
Highest
$839,239 $69,055 $908,294
Scott Armstrong MD PHD Chair of Pediatric Oncology 50.0
Highest
$819,691 $81,122 $900,813
John O Chesley ESQ Counsel 0.0
$456,000 $0 $456,000
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 $3,471,594,710 $3,358,144,757 $5,348,876,627 $113,449,953
2023 $3,387,587,769 $3,002,803,859 $4,735,245,065 $384,783,910
2022 $2,669,084,593 $2,558,704,532 $4,291,020,227 $110,380,061
2021 $2,417,795,330 $2,225,842,004 $4,549,977,055 $191,953,326
2020 $2,005,205,411 $1,969,358,412 $3,905,849,954 $35,846,999
2019 $1,985,509,644 $1,883,293,263 $3,127,097,000 $102,216,381
2018 $1,755,138,116 $1,681,302,389 $2,890,706,000 $73,835,727
Explore More Nonprofits
Top 100 Nonprofits in Massachusetts Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare Dana-Farber Cancer Institute Inc with other nonprofits in Massachusetts and across the country.